Paul Pollack

AbbVie (United States) · US

Area of research

Genetics · Epidemiology

Research interest

Research focused on Crohn's disease and Ustekinumab, with related work in Crohn disease, Randomized controlled trial, Disease. Notable publications include 'Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease', 'Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn’s Disease', and 'Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial'.

h-index

—

citations

257

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial

Clinical Gastroenterology and Hepatology 2023cited by 16position: middledoi

Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn’s Disease

Gastroenterology 2019cited by 65position: middledoi

Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease

Gastroenterology 2018cited by 176position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Brian G. Feagan · Western University3 papers (2018–2023)Gert De Hertogh · Spaarne Gasthuis2 papers (2019–2023)— · 2 papers (2018–2019)William J. Sandborn · Mirati Therapeutics (United States)2 papers (2018–2019)Daphne Chan · Johnson & Johnson (United States)2 papers (2018–2019)Paul Rutgeerts · KU Leuven2 papers (2018–2019)— · 1 papers (2018–2018)Emily Hon · Indiana University School of Medicine1 papers (2023–2023)Omoniyi J. Adedokun · Johnson & Johnson (United States)1 papers (2018–2018)Vipul Jairath · Western University1 papers (2023–2023)Joshua R. Friedman · Spark Therapeutics (United States)1 papers (2019–2019)Walter Reinisch · Reed Medical (United Kingdom)1 papers (2023–2023)Jean‐Frédéric Colombel · Cornell University1 papers (2018–2018)Carrie Brodmerkel · IGM Biosciences (United States)1 papers (2019–2019)Feifei Yang · Xi'an University of Science and Technology1 papers (2019–2019)— · 1 papers (2023–2023)— · 1 papers (2018–2018)Katherine Li · Johnson & Johnson (United States)1 papers (2019–2019)Fernando Magro · Universidade do Porto1 papers (2023–2023)Rish K. Pai · Sinai Health System1 papers (2023–2023)